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While studies of organ development have traditionally relied onmodel organisms, recent advances in embry-
onic stem cell (ESC) culture allow investigation of organogenesis in human cells. Wang et al. (2015) employ
this system to map the dynamic enhancer landscape during ESC differentiation to the endoderm derivatives
pancreas and liver.Through decades of studies in model
organisms ranging from nematodes to
mice, a general framework has emerged
that explains the transitions from the
pluripotent zygote to hundreds of specific
cell fates in its differentiated descendants.
Thus, both extrinsic, inductive signals, as
well as the intrinsic regulation of gene
expression by stage-specific DNA bind-
ing transcription factors, have been
shown to direct lineage specification and
organ development. A complex assort-
ment of epigenetic marks accompanies
these fate transitions. In this issue of Cell
Stem Cell, Wang and colleagues employ
comprehensive mapping of two key
enhancer marks during the in vitro differ-
entiation of human embryonic stem cells
(hESCs) toward the pancreatic and he-
patic lineages to unravel the epigenomic
landscape of stepwise endoderm differ-
entiation into these alternative cell fates
(Wang et al., 2015).
Wang and colleagues employ a well-
validated, stepwise in vitro differentiation
system, pioneered by D’Amour and col-
leagues (D’Amour et al., 2006), in which
ESCs are first induced to form ‘‘definitive
endoderm,’’ the germ layer from which
the gut-associated organs thyroid, lung,
liver, pancreas, and the epithelia of the
entire gastrointestinal tract are derived.
These definitive endoderm cells are
then further differentiated, using various
growth factors andmedium supplements,
into ‘‘gut tube,’’ ‘‘foregut endoderm,’’ and
finally ‘‘pancreatic endoderm’’ cells. At
each of these stages, the authors deter-
mined the global transcriptome using
RNA-seq, the approximate transcriptional
rate by global run-on sequencing, and the
distribution of two key ‘‘enhancer marks.’’
The histone H3 lysine 4 mono-methyl
(H3K4me1) modification, while also foundnear active promoters, is widely accepted
as a mark of enhancers, regardless of
whether they are ‘‘poised’’ or ‘‘active.’’
The H3K27Ac (histone H3 acetylated
on lysine 27) is typically present at the
subset of enhancers that are active,
increasing transcription from a nearby or
even distant target promoter. By perform-
ing this comprehensive analysis, the
authors confirmed that on a global level,
transcription at enhancers, producing
so-called ‘‘eRNAs,’’ occurs mostly when
these carry the H3K27Ac mark.
When cataloguing active versus poised
enhancers during their differentiation
protocol toward the pancreatic lineage,
the authors noted that a large fraction
of poised enhancers present at the defin-
itive endoderm or gut tube stages never
become activated during the directed dif-
ferentiation process. Considering that the
gut tube gives rise to multiple organs,
this finding is not surprising. Indeed, the
authors demonstrate that many of these
poised enhancers become activated
when they differentiate gut tube cells to-
ward either liver or lung fates. It is likely
that yet other subsets of enhancers
that are poised in the gut tube stage
would become active if the cells were
differentiated into thyroid-like or colonic
epithelium-like cells. Altogether, these
findings suggest that the establishment
of a large set of poised enhancers
contributes to the acquisition of devel-
opmental competence during stem cell
differentiation.
So how are these gut tube enhancers
specified in the first place? Using
both transcription factor recognition motif
analysis and chromatin immunopre-
cipitation followed by high throughput
sequencing (ChIP-seq) for selected tran-
scription factors, the authors find thatCell Stem Cethe FOXA transcription factors occupy a
large fraction of the enhancers that are
poised at the gut tube stage, but they
become active after differentiation to
either pancreas or liver lineages. The
FOXA proteins are the founding members
of a large class of ‘‘winged helix transcrip-
tion’’ factors that play essential roles in
multiple tissues and were discovered
almost 3 decades ago (Hannenhalli and
Kaestner, 2009). Seminal work by Zaret
and colleagues showed early on that the
FOXA proteins, which are structurally
related to linker histones, can displace nu-
cleosomes from their target sites in an
in vitro assay (McPherson et al., 1993),
and are therefore referred to as pioneer
transcription factors. More recently, the
FOXA proteins were shown to be impor-
tant in global nucleosome repositioning
during in vitro differentiation of ESCs to
pre-hepatic endoderm (Li et al., 2012).
In the current paper, Wang and col-
leagues employ shRNA against FOXA1,
one of the three FOXA proteins, to show
that this gene is required for full induction
of pancreatic marker gene expression
in the in vitro differentiation system. This
finding confirms genetic data in mice,
which demonstrated that in vivo ablation
of Foxa1 and Foxa2 in the pancreatic pri-
mordium blocked pancreas development
and the induction of Pdx1 (Gao et al.,
2008). In fact, the Foxa proteins are
required for the proper development of
all gut-tube-derived organs where their
contribution has been tested, such as
lung, liver, and pancreas (Gao et al.,
2008, 2010; Lee et al., 2005; Wan et al.,
2005), and the current manuscript pro-
vides the molecular explanation for these
findings from mouse genetics by docu-
menting that the FOXA proteins bind to a
large fraction of enhancers that becomell 16, April 2, 2015 ª2015 Elsevier Inc. 343
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Previewsactivated during lineage development
from gut endoderm.
In their shRNA gene suppression
experiment, reducing FOXA1 expression
by 50%, the authors also analyzed the
enrichment for the H3K4me1 mark at six
selected enhancers and found no differ-
ence compared to controlled cells. They
suggest that FOXA1might not be involved
directly in establishing this mark. While
this is of course possible, the data on
this point are not definitive, as genetic ex-
periments have shown partial redundancy
among the Foxa factors in multiple in-
stances (Gao et al., 2008; Li et al.,
2009; Wan et al., 2005). Thus, it is likely
that a 50% reduction in FOXA1 levels as
achieved by the authors is compensated
in part by continued presence of FOXA2
and FOXA3. Therefore, it remains to be
seen if these FOXA bound enhancers
can be established during hESC differen-
tiation without any FOXA protein present.
In summary, the comprehensive study
by Wang and colleagues demonstrates344 Cell Stem Cell 16, April 2, 2015 ª2015 Elthat the establishment of developmental
competence during hESC differentiation
toward the endoderm-derived organs oc-
curs in a stepwisemanner, with entire sets
of enhancers first poised and then acti-
vated depending on which lineage is tar-
geted. In addition, these enhancers are
first occupied by the winged helix tran-
scription factors FOXA1 and FOXA2
during the acquisition of developmental
competence, while lineage-specific tran-
scription factors are recruited at subse-
quent steps. These findings suggest that
effective reprogramming of somatic cells
might require both the action of pioneer
factors, such as the FOXA proteins, and
lineage-specific transcription factors for
full activation of the transcriptome appro-
priate for a given lineage.
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Long noncoding RNAs (lncRNAs) influence diverse cellular processes and have been implicated in regulating
stem cell properties. Now in Cell Stem Cell, Ramos et al. (2015) demonstrate that the neural-specific lncRNA
Pnky regulates neuronal differentiation from neural stem cells and mediates RNA splicing through interac-
tions with polypyrimidine tract-binding protein 1 (PTBP1).lncRNAs are noncoding transcripts that
are increasingly appreciated as important
regulators of cellular function. They are
greater than 200 nucleotides in length
and, similar to protein-coding transcripts,
undergo capping, polyadenylation, and
splicing. lncRNAs are often expressed in
a highly cell type-dependent or tissue-
specific manner, but they exhibit lower
conservation at the sequence level com-
pared to protein-coding RNAs (Batistaand Chang, 2013). While previously
considered as transcriptional junk, recent
evidence suggests that lncRNAs par-
ticipate in many cellular regulatory pro-
cesses including X chromosome inactiva-
tion, epigenetic chromatin modification,
RNA processing, and transcriptional and
post-transcriptional control of gene ex-
pression (Batista and Chang, 2013).
Importantly, recent studies have demon-
strated that lncRNAs are crucial playersin the pluripotency network. The lncRNAs
Gomafu (AK028326) and AK141205 are
involved in the maintenance of pluripo-
tency in mouse embryonic stem cells
(mESCs) (Sheik Mohamed et al., 2010),
while others, for instanceMistral, promote
mESC differentiation (Bertani et al., 2011).
Now in Cell Stem Cell, Ramos et al. (2015)
demonstrate that the lncRNA Pnky re-
gulates differentiation of embryonic and
postnatal neural stem cells (NSCs).
